[Ip-health] Novartis Funded Max Foundation Supports...Novartis

[Benjamin Krohmal]

Yesterday the cancer NGO Max Foundation, which administers Novartis'
Glivec International Patient Assistance Program (GIPAP), posted a
letter on its web page defending Novartis and criticizing CPAA.  The
letter also touts a network of "Friends of Max" patient groups
"inspired by their gratitude for Novartis' program."

Regarding Novartis' Medicine Glivec and Patent Protection in India.
Jan 28 2007
Setting the record straight about =93the Glivec Story=94

<snip>
"In 2002 Novartis launched GIPAP in an unprecedented act of corporate
responsibility and generosity. This program, administered globally by
The Max Foundation, has a unique model through which patients who
meet program criteria are accepted into the program and receive
continuous supply of free Glivec as prescribed by their physicians."
<snip>

full letter available here: https://www.maxaid.org/Default.aspx?
trgt=3Dnewsstories&choice=3D66

Benjamin Krohmal
Coordinator - Project on Medical Innovation
Consumer Project on Technology
Tel: +1-202-332-2670 ex. 14
Fax: +1-202-332-2673
ben.krohmal@cptech.org